Blavy G, Kouame C
Laboratorie d'hématologie, Faculté de Pharmacie, Abidjan, Côte d'Ivoire.
Nephrologie. 1994;15(6):387-9.
Antithrombin III activity was determined in 96 ivorian adults clinically divided into 3 groups: I) nephrotic syndrome, II) chronic renal failure, and III) terminal uremia requiring maintenance dialysis. In the nephrotic syndrome, a significative decrease of antithrombin III is found, which can explain the existence of thrombotic complications. In chronic renal failure and terminal uremia, antithrombin III activity is normal, and thromboembolic events may be related to a deficiency of other inhibitors of the coagulation.
对96名成年科特迪瓦人测定了抗凝血酶III活性,这些人临床上分为3组:I)肾病综合征,II)慢性肾衰竭,III)需要维持性透析的终末期尿毒症。在肾病综合征中,发现抗凝血酶III显著降低,这可以解释血栓形成并发症的存在。在慢性肾衰竭和终末期尿毒症中,抗凝血酶III活性正常,血栓栓塞事件可能与其他凝血抑制剂缺乏有关。